A new study has identified over 240 scientific publications on animal models of hemorrhagic stroke that contain potentially problematic images, thereby raising concerns about the trustworthiness of the body of literature this field. The findings come from a team led by René Aquarius and Kim Wever at Radboud university medical center in the Netherlands, and are published October 30^th in the open-access journal PLOS Biology.

Researchers often use images in their publications to provide evidence of whether a treatment works, for example, by showing the presence or absence of specific proteins or cells or changes in brain tissue. But the researchers found many instances of image duplication within publications, as well as across different publications, even when authors claimed the images came from separate experiments with different experimental conditions. This kind of duplication can cast doubt on the validity of the study’s conclusions and its scientific integrity.

Originally, the team set out to systematically review animal studies on early brain injury following hemorrhagic stroke to find promising treatments suitable for clinical testing. But after noticing suspicious images in some papers in mid-2023, they set out to perform a systematic investigation of image-related problems in all 608 potentially relevant publications. The researchers uncovered that 243 papers (40%) were found to be problematic, most often for containing problematic images.

These findings raise concerns about the overall trustworthiness of animal-based research in this field. The authors stress the need for journals and publishers to investigate these issues carefully and take corrective editorial action where necessary. The scientific record needs to be as error-free as possible in order for scientists, clinicians and policymakers to make well-informed, evidence-based decisions that benefit patients’ health.

The authors add, “We found a high prevalence (40%) of papers with image-related issues among preclinical literature on early brain injury after hemorrhagic stroke.

“These findings shocked us to our core and might explain why, in spite of hundreds of animal studies published in this field, we still do not have any effective treatments for early brain injury in hemorrhagic stroke patients.

“During the summer break of 2023 we were texting each other figures from papers to collectively find image overlaps. Every time a new message came in, we knew somebody had found yet another inappropriate image overlap. It was at this moment that we knew that we had a serious problem on our hands that we needed to investigate in a systematic way.”

In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology:

Citation: Aquarius R, van de Voort M, Boogaarts HD, Reesink PM, Wever KE (2025) High prevalence of articles with image-related problems in animal studies of subarachnoid hemorrhage and low rates of correction by publishers. PLoS Biol 23(10): e3003438.

Author countries: The Netherlands

Funding: see manuscript

The complaint centers on the premise that ASU’s decision to use animals, particularly mice, in studying dietary choline supplementation runs counter to established federal policies advocating for the replacement of animal models where feasible. Choline, a nutrient well-documented for its safety and efficacy in human clinical research, including studies involving individuals with Down syndrome, does not warrant invasive animal experimentation according to the PCRM’s assessment. The most contentious aspect lies in the assertion that these animal models not only lack scientific merit but also constitute a form of research misconduct due to their failure to abide by the Public Health Service Policy on humane animal use.

Arizona State University’s study, funded in part by the NIH, involved administering choline supplements to 67 mice over a protracted period of ten months. The research employed highly invasive methods including brain implants and involved terminal procedures where the animals were euthanized to collect brain and liver samples for analysis. The procedures imposed significant distress and harm to the animals, raising questions about the ethical ramifications and adherence to the principles of humane treatment encapsulated in federal guidelines. The PCRM argues that such approaches are unnecessary given the availability of consenting human subjects for non-invasive research on nutritional interventions.

At the heart of the PCRM’s argument is the well-documented inadequacy of mouse models to accurately replicate the complex biology and genetics of Down syndrome — a human chromosomal condition defined by trisomy 21, involving multifaceted physiological and cognitive dimensions that are species-specific. Decades of reliance on murine models have consistently failed to produce clinically effective treatments, a fact that underscores the translational disconnect between animal studies and human applications. This historical context forms a critical backdrop to the current challenge, emphasizing why continuing animal-based methods may be obstructive rather than constructive.

Federal guidelines guiding laboratory animal use emphasize the principles of the Three Rs: Replacement, Reduction, and Refinement. These principles demand researchers prioritize alternatives to animal use whenever feasible, minimize the number of animals employed, and employ techniques that decrease pain or distress. The PCRM’s complaint highlights a perceived failure by ASU’s principal investigator to justify why animal models were necessary in this instance, particularly given the “abundance of clinical research” already available on choline in humans. The omission of a rationale aligning with these principles signifies a potential violation of federally mandated research standards.

The broader implications of this controversy reflect a growing scientific movement advocating for the adoption of modern, human-relevant methodologies that bypass animal models entirely. Emerging technologies such as tissue chips, organoids, computational simulations, and high-throughput screening offer compelling alternatives that can more accurately capture human physiological variability and complex disease mechanisms, including those pertinent to genetic conditions like Down syndrome. These technologies not only enhance the biological relevance of findings but also accelerate drug development pipelines by providing more predictive and ethically responsible platforms.

Public sentiment appears to be increasingly aligned with this shift toward non-animal research modalities. A September 2024 joint survey conducted by the Physicians Committee and Morning Consult revealed that over 85% of respondents support phasing out animal-based research in favor of superior, animal-free methods. This majority perspective adds a social and ethical dimension to the scientific critique, signaling that continued reliance on animal models may encounter mounting resistance not just from within the scientific community but from broader society.

The ASU study also raises critical questions about resource allocation within biomedical research. Persistent expenditures on animal-based projects that show limited translational success potentially divert funding and focus away from more promising translational science avenues that could yield tangible benefits for those affected by Down syndrome. Prioritizing human-relevant research methods might expedite therapeutic discoveries while adhering to ethical responsibilities, a dual imperative faced by modern biomedical research institutions.

In response to the complaint, the Physicians Committee has urged the NIH to thoroughly investigate the matter, seek corrective actions, and impose appropriate penalties if warranted. This call to action reflects a broader institutional commitment to uphold scientific integrity and ethical standards in federally funded research programs. It also highlights the role of oversight bodies in enforcing compliance with policies designed to safeguard animal welfare and enhance the scientific validity of research outcomes.

The controversy exemplifies ongoing debates regarding the scientific validity of animal experimentation in complex human diseases and conditions. While animal research has historically contributed to biomedical knowledge, its limitations in modeling human-specific pathophysiology and genetics are increasingly apparent. Down syndrome, with its intricate chromosomal and developmental intricacies, may particularly highlight these limitations, reinforcing arguments favoring a paradigm shift toward alternative models that better mimic human biology.

Moreover, the ethical concerns extend beyond scientific validity into the realm of animal welfare. The use of invasive and painful procedures, coupled with the ultimate euthanasia of study animals, demands stringent scrutiny and transparent justification. Ethical research necessitates balancing potential human benefits against animal harm, a balance challenged when effective human-centric alternatives are available. This case could set a precedent in how institutional animal care and use committees evaluate and approve research protocols involving animals.

As the debate unfolds, it is likely to stimulate further discourse among researchers, policymakers, funding agencies, and advocacy groups about redefining standards and expectations in biomedical research. The push for technologically advanced models capable of simulating human biological systems and diseases is reshaping research strategies. If institutions continue to rely on outdated animal-based experiments, they risk lagging behind scientific innovation and ethical standards, potentially compromising both credibility and impact.

In conclusion, the PCRM’s complaint against Arizona State University encapsulates a critical juncture in biomedical research ethics and methodology. It underscores the urgent need to reassess the role of animal experimentation, especially for conditions like Down syndrome where effective human-based research methods already exist. The scientific community’s response to this challenge may pave the way for a more humane, effective, and translationally relevant future in medical science.

—

Subject of Research: Animals

Article Title: Physicians Committee Challenges Arizona State University’s Use of Mice in Down Syndrome Dietary Supplement Study

News Publication Date: May 19, 2025

Web References:
– Complaint Document: https://pcrm.widen.net/s/sgvchbcdvp/letter-to-olaw_arizona-state-university_may-2025
– Initial Letter to ASU: https://pcrm.widen.net/s/tqr6qw6gfx/asu-university
– Survey Results: https://pcrm.widen.net/s/qzfxtfh7bw/animal-testing-survey

Keywords:
Applied research, Pharmacology, Animal experimentation, Down syndrome, Dietary supplements, Choline, Biomedical ethics, Translational research, Alternatives to animal testing, Laboratory animal welfare, Human-relevant models

The research aims to explore the challenges faced by patients seeking emergency medical care for brain injuries linked to intimate partner violence. However, critics, including Dr. Carol Tavani, a psychiatrist with emergency medicine credentials, argue that the methodologies applied in this study are not only scientifically flawed but also grossly unethical. They highlight that there are existing, well-established protocols for diagnosing and managing non-fatal strangulation and traumatic brain injury in humans, suggesting that the study fails to justify the suffering inflicted on the animal subjects.

According to the letter penned by Dr. Tavani and Janine McCarthy, the science policy program manager for the Physicians Committee, the use of rats in this manner violates essential ethical standards and the journal’s own guidelines governing animal research. The letter calls for the retraction of the study, asserting that its publication legitimizes an approach that could normalize similar harmful practices in the future. The authors contend that the research contributes nothing valid to the understanding of human health and instead encourages a continued legacy of cruelty in the name of scientific inquiry.

Justifying their call for retraction, the representatives from the Physicians Committee assert that the ethical questions surrounding this research go beyond mere animal rights. They contend that the drastic physiological and neurological differences between rats and humans render such experiments inadequate for drawing conclusions relevant to human behavior and health outcomes. This realization prompts a wider imperative: to develop research methodologies that prioritize human health and utilize models more reflective of human conditions.

Delving into the specifics of the study, it is revealed that 109 young female rats were subjected to what the researchers termed "mild" traumatic brain injuries, which were induced by a metal plate that delivered a forceful blow to their heads. Following this, the experimental protocol involved strangling these animals with a weighted band that exerted significant pressure on their necks. The methodology culminated in dissection post-experiment, raising alarm bells over the ethical inconsistency and brutality of the investigative nature of the work.

Those concerned with ethical standards in research emphasize that the implications of such studies extend beyond animal welfare. By normalizing the infliction of trauma on animal subjects, researchers risk setting a troubling precedent that may encourage further inhumane practices under the guise of scientific exploration. In a world increasingly leaning toward empathy and compassion, efforts toward promoting greater respect for animal rights must be acknowledged, especially when superior human-specific models and research methodologies exist.

Public sentiment appears to echo these concerns. A survey conducted in September 2024 revealed that a significant majority—over 85% of participants—support the phasing out of animal-based research, advocating instead for research methodologies that harness human-specific models. This shift in public opinion signifies a growing awareness and demand for the ethical treatment of animals in research settings, alongside a call for advances in human-centered research approaches.

In their public communication, McCarthy stated unequivocally, “Inducing strangulation and brain injury in animals is not only ethically troubling—it fails to produce scientifically valid insights relevant to human health.” The emphasis placed on prioritizing the well-being of humans suffering from intimate partner violence speaks powerfully to the necessity of fostering research that can truly inform interventions and improve care for these individuals, without the unnecessary suffering of animal subjects.

The growing concerns surrounding this study encapsulate a moment of reckoning for the scientific community, pushing for a deeper reflection on the methods employed in the pursuit of knowledge. Ethical considerations must be foregrounded in discussions around animal research, particularly when robust alternatives already exist. This discourse could potentially shape future research directions and instigate reforms in how studies are designed and executed across various fields, effectively directing efforts toward compassionate and humane practices.

The controversy also sheds light on the broader narrative around the scientific legitimacy of animal models in research. As the understanding of human health continues to evolve, the reliance on animal models is increasingly questioned. A paradigm shift is crucial—moving toward innovative research methods that honor the complexity of human biology and experience. By embracing human-specific models, researchers can better ensure that their findings are applicable and meaningful while actively contributing to the improvement of healthcare for individuals affected by experiences of violence.

Ultimately, the ethical dimensions of this research issue resonate far beyond the original study published in Brain, Behavior, and Immunity. This episode serves as a critical reminder of the pressing need for ethical vigilance within the scientific community and demands accountability from researchers to consider the implications of their methodologies. Engaging with the moral complexities of research is vital to fostering an environment in which science can thrive, informed not just by a quest for knowledge, but by a commitment to compassion and ethical praxis.

As the discussions surrounding this study develop, it is essential for the scientific community to address the underlying ethical questions head-on. We stand at a crossroads, with an opportunity to redefine the future of research—ensuring that the pursuit of knowledge does not come at the cost of suffering for any sentient being. The momentum generated by advocacy groups, public sentiment, and ethical accountability could lead the way toward a healthier, more compassionate scientific future.

Subject of Research: Animals
Article Title: Ethical Concerns Arise Over Animal-Based Research on Brain Injuries
News Publication Date: March 24, 2025
Web References: Physicians Committee for Responsible Medicine, Australian Study
References: Physicians Committee for Responsible Medicine (2024).
Image Credits: N/A
Keywords: Animal research, brain injuries, ethical implications, intimate partner violence, humane research methods.